Lorazepam Effects on Neuroimaging Measures

Clinical trial NCT04671836 · WITHDRAWN

Trial details

NCT number: NCT04671836
Sponsor: Northwell Health
Status: WITHDRAWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Lorazepam Neuroimaging

Start date: 2022-01-01
Primary completion: 2022-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.